Chronic Pain Network

Co-Applicant

Dr. Louis Gendron professor in the Department of Pharmacology and Physiology of the Faculty of Medicine and Health Sciences at the Université de Sherbrooke. He is also Director of the Inflammation-Pain Axis of the CHUS Research Center and an active member of the Quebec Network for Pain Research (RQRD) and the Sherbrooke Institute of Pharmacology (IPS). Dr. Gendron's research focuses on the delta opioid receptor, a G protein-coupled receptor (GPCR) of interest in the treatment of chronic pain. Using cellular techniques and adapted techniques for the study of animals, his team seeks to characterize the mechanism of action, regulation and cellular trafficking of the opioid delta receptor, as well as its roles in the treatment of pain, Anxiety and depression. Professor Gendron is also an associate editor in the journal Progress in Neuro-Psychopharmacology & Biological Psychiatry.